EditCo Bio
Alma Ines O. is an experienced Global Strategic Account Manager currently at EditCo Bio since March 2024, previously serving at Synthego Corporation in various managerial roles from November 2021 to April 2024. Prior experience includes positions as a Biosciences Account Manager at Thermo Fisher Scientific and CEO, co-founder, and Sales Manager at TransAtlantic Investors, where Alma piloted strategic business development in the competitive San Francisco real estate market. Alma's background also encompasses engineering project management at Merck Millipore, process engineering at Exogen Biotechnology, and bioengineering research at Berkeley Lab and UC Berkeley. Alma holds a Master of Science in Biomechanical Engineering and a Bachelor of Science in Mechanical and Industrial Engineering, with foundational education in engineering from Lycée Pasteur, France.
This person is not in any teams
EditCo Bio
Whatever your edit, we can make it easier with optimized, multi-guide CRISPR kits and made-to-order edited cells. We're dedicated to building a novel research toolkit to make genome engineering simpler and more efficient. EditCo's CRISPR expertise and highly automated manufacturing allows us to engineer a wide variety of cell lines with the speed, consistency, and functionality than can redefine research. Leave CRISPR to us–you focus on discoveries.